Company research
Comera Life Sciences Holdings, Inc.
CIK 1907685Updated Oct 6, 2026
SecuritiesCMRA · OTC · equityCMRAW · OTC · warrant
Historical securities (2)
CMRA · NASDAQ · equity · closed Nov 16, 2023CMRAW · NASDAQ · warrant · closed Nov 16, 2023CMRA price & chart
Loading TradingView…
OTC:CMRA on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2023 | Q3 2022 | Q3 2021 | Q2 2023 | Q2 2022 | Q2 2021 | Q1 2023 | Q1 2022 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||
| AssetsUSD | 3,071,949Source | 4,937,119Source | — | 2,340,172Source | 6,130,667Source | — | 2,999,117Source | — | 3,727,113Source | 7,417,814Source |
| Property, Plant and Equipment, NetUSD | 186,738Source | 192,590Source | — | 209,732Source | 216,380Source | — | 234,576Source | — | 257,186Source | 234,167Source |
| Current assets: | ||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 1,767,870Source | 2,669,354Source | 8,269,230Source | 476,302Source | 4,938,788Source | 6,924,746Source | 1,538,653Source | 3,863,101Source | 446,607Source | 6,510,140Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | 293,821Source | — | 250,000Source | 100,000Source | — | — | — | 34,320Source | — |
| Assets, CurrentUSD | 2,630,496Source | 4,288,928Source | — | 1,824,034Source | 5,410,849Source | — | 2,407,437Source | — | 3,063,098Source | 6,781,074Source |
| Prepaid Expense and Other Assets, CurrentUSD | 862,626Source | 1,325,753Source | — | 1,072,719Source | 372,061Source | — | 868,784Source | — | 986,499Source | 270,648Source |
| Operating Lease, Right-of-Use AssetUSD | 161,515Source | 362,401Source | — | 213,206Source | 410,238Source | — | 263,904Source | — | 313,629Source | 320,373Source |
| LIABILITIES AND EQUITY | ||||||||||
| LiabilitiesUSD | 2,969,685Source | 3,933,289Source | — | 4,000,136Source | 3,577,724Source | — | 3,659,435Source | — | 5,456,491Source | 1,246,608Source |
| Stockholders’ equity: | ||||||||||
| Common Stock, Value, IssuedUSD | 2,759Source | 1,665Source | — | 1,915Source | 1,594Source | — | 1,915Source | — | 1,671Source | 31Source |
| Retained Earnings (Accumulated Deficit)USD | -40,950,566Source | -31,941,329Source | — | -38,796,855Source | -28,864,488Source | — | -37,385,235Source | — | -34,903,923Source | -16,899,825Source |
| Stockholders' Equity Attributable to ParentUSD | -4,220,602Source | -3,428,008Source | -13,660,316Source | -6,350,362Source | -1,792,079Source | -12,004,778Source | -5,264,844Source | -17,093,656Source | -6,247,088Source | -14,686,247Source |
| Additional Paid in Capital, Common StockUSD | 36,727,205Source | 28,511,656Source | — | 32,444,578Source | 27,070,815Source | — | 32,118,476Source | — | 28,655,164Source | 2,213,547Source |
| Liabilities and EquityUSD | 3,071,949Source | 4,937,119Source | — | 2,340,172Source | 6,130,667Source | — | 2,999,117Source | — | 3,727,113Source | 7,417,814Source |
| Current liabilities: | ||||||||||
| Liabilities, CurrentUSD | 2,932,419Source | 3,430,081Source | — | 3,953,545Source | 2,523,906Source | — | 3,355,021Source | — | 5,058,682Source | 1,045,104Source |
| Operating Lease, Liability, CurrentUSD | 171,596Source | 195,253Source | — | 221,879Source | 191,400Source | — | 217,500Source | — | 199,184Source | 121,552Source |
| Accounts Payable, CurrentUSD | 1,144,822Source | 1,436,692Source | — | 2,150,774Source | 1,425,729Source | — | 1,772,187Source | — | 1,458,267Source | 416,941Source |
| Operating Lease, Liability, NoncurrentUSD | — | 171,596Source | — | — | 221,879Source | — | 53,669Source | — | 120,302Source | 201,504Source |
| Additional Financial Items | ||||||||||
| Accrued Liabilities, CurrentUSD | — | 887,012Source | — | — | 906,777Source | — | 1,365,334Source | — | 1,295,764Source | 506,611Source |
| Deferred Revenue, CurrentUSD | — | — | — | 36,310Source | — | — | — | — | 144,280Source | — |
| Long-term Debt, Current MaturitiesUSD | 389,872Source | 911,124Source | — | 584,809Source | — | — | — | — | 455,562Source | — |
cash flow · annual statements
| Line item | Q4 2022 | Q4 2021 | Q3 2023 | Q3 2022 | Q2 2023 | Q2 2022 | Q1 2023 | Q1 2022 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -2,153,711Source | -3,076,841Source | -1,411,620Source | -9,085,268Source | -2,481,312Source | -2,879,395Source | -18,004,098Source | -5,451,778Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||
| Changes in operating assets and liabilities: | ||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -34,320Source | 148,000Source | 34,320Source | -109,868Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 126,423Source | 123,024Source | 862,920Source | 319,325Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -1,905,768Source | -2,869,552Source | -9,771,770Source | -3,757,949Source |
| Cash flows from investing activities: | ||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -88,359Source | — | -28,607Source | -142,013Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 88,359Source | — | 28,607Source | 142,013Source |
| Cash flows from financing activities: | ||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 1,580,548Source | 222,513Source | 5,242,469Source | 10,279,675Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | 455,562Source | — | 1,060,438Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -413,579Source | -2,647,039Source | -4,557,908Source | 6,379,713Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 1,817,870Source | 2,719,354Source | 526,302Source | 4,988,788Source | 1,588,653Source | 3,913,101Source | 2,002,232Source | 6,560,140Source |
| Additional Financial Items | ||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 267,560Source | 127,690Source | 278,969Source | 56,739Source | 300,765Source | 42,556Source | 375,790Source | 1,114,656Source |
| DepreciationUSD | — | — | 23,000Source | 24,000Source | 25,000Source | 22,000Source | 28,260Source | 24,774Source | 93,947Source | 86,136Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | — | 160,588Source |
| General and Administrative ExpenseUSD | — | — | 1,885,405Source | 2,314,554Source | 1,503,553Source | 3,696,517Source | 2,433,147Source | 2,016,245Source | 10,652,894Source | 3,941,783Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | — |
| Nonoperating Income (Expense)USD | — | — | 3,360Source | -541,446Source | 68,614Source | -5,112,381Source | 19,144Source | -426,743Source | -6,034,083Source | 83,850Source |
| Operating ExpensesUSD | — | — | 2,251,420Source | 2,709,354Source | 1,739,249Source | 4,065,070Source | 2,776,852Source | 2,503,462Source | 12,392,727Source | 5,694,452Source |
| Other Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | -426,666Source | -426,666Source | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 49,158Source | — | 829,469Source | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | 429,430Source | 659,501Source | 180,000Source |
income statement · annual statements
| Line item | Q4 2022 | Q4 2021 | Q3 2023 | Q3 2022 | Q2 2023 | Q2 2022 | Q1 2023 | Q1 2022 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 136,310Source | 234,922Source | 315,055Source | 146,726Source | 392,915Source | 95,334Source | 633,102Source | 319,832Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — | — | — |
| Operating Income (Loss)USD | — | — | -2,157,071Source | -2,535,395Source | -1,480,234Source | -3,972,887Source | -2,500,456Source | -2,452,652Source | -11,970,015Source | -5,535,628Source |
| Other Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | -426,666Source | -426,666Source | — |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | — |
| Earnings Per Share, BasicUSD per share | — | — | -0.1Source | -0.2Source | -0.08Source | -1.14Source | -0.13Source | -4.01Source | -1.76Source | -1.81Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.1Source | -0.2Source | -0.08Source | -1.14Source | -0.13Source | -4.01Source | -1.76Source | -1.81Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 23,113,051Source | 16,024,011Source | 19,154,681Source | 8,142,383Source | 19,033,436Source | 718,419Source | 10,452,697Source | 3,012,603Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 23,113,051Source | 16,024,011Source | 19,154,681Source | 8,142,383Source | 19,033,436Source | 718,419Source | 10,452,697Source | 3,012,603Source |
| Additional Financial Items | ||||||||||
| General and Administrative ExpenseUSD | — | — | 1,885,405Source | 2,314,554Source | 1,503,553Source | 3,696,517Source | 2,433,147Source | 2,016,245Source | 10,652,894Source | 3,941,783Source |
| Interest ExpenseUSD | — | — | 5,965Source | 12,696Source | 3,977Source | — | 7,618Source | 77Source | 20,391Source | — |
| Nonoperating Income (Expense)USD | — | — | 3,360Source | -541,446Source | 68,614Source | -5,112,381Source | 19,144Source | -426,743Source | -6,034,083Source | 83,850Source |
| Operating ExpensesUSD | — | — | 2,251,420Source | 2,709,354Source | 1,739,249Source | 4,065,070Source | 2,776,852Source | 2,503,462Source | 12,392,727Source | 5,694,452Source |
| Research and Development ExpenseUSD | — | — | 366,015Source | 394,800Source | 235,696Source | 368,553Source | 343,705Source | 487,217Source | 1,739,833Source | 1,752,669Source |